Biomarkers & Immuno-Oncology World Congress 2018
The Leading Annual Meeting Where Big Pharma and Biotech Drive Innovation and Collaboration in Biomarkers, Diagnostics and Immunotherapy
Create Account for pricing
The Biomarkers and Immuno-Oncology World Congress brings togather a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers - making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. Now in its fourteenth year, the Biomarkers and Immuno-Oncology World Congress is the leading annual meeting dedicated to biomarkers, diagnostics, and immuno-oncology research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall.
![]()
